Drug-resistant bacteria are a growing threat, making common infections harder to treat. But a new review of existing research suggests a surprising ally: bacteriophages, viruses that naturally attack bacteria. When paired with quinolone antibiotics, phages can help overcome resistance in several ways.
The review found that this combination, called phage-antibiotic synergy, works by remodeling bacterial cells, activating dormant phages inside bacteria, breaking down protective biofilms, and even boosting the immune system. These effects can slow the evolution of resistance.
However, it's not always a win. High doses of antibiotics can actually interfere with phage activity, and bacteria can adapt in ways that block the synergy. The key, researchers say, is careful timing and dosing: using lower antibiotic levels and the right amount of phages.
This is a systematic review, meaning it summarizes findings from many studies, but it doesn't provide new clinical trial data. The evidence is promising but early, and more research is needed to turn this into real-world treatments.